PPBT (Purple Biotech) Institutional Ownership: 8.12% (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PPBT Purple Biotech Ltd PPBT
19 GF Score
Price $1.35
! 2 Warning Signs
View Full Analysis

What is Purple Biotech Institutional Ownership?

Purple Biotech PPBT -2.87% 19 Institutional Ownership is 8.12% as of Jul. 22, 2026. GuruFocus rates PPBT with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Purple Biotech's institutional ownership is 8.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Purple Biotech's Insider Ownership is 0.17%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Purple Biotech's Float Percentage Of Total Shares Outstanding is 100.20%.

Purple Biotech Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Purple Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Purple Biotech Institutional Ownership Chart

Purple Biotech Historical Data

The historical data trend for Purple Biotech can be seen below:

2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-07-31 2024-08-31 2024-09-30 2024-10-31
Institutional Ownership 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.04
PPBT
19GF Score
Purple Biotech Ltd PPBT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Purple Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 8.12% mean?
Purple Biotech (PPBT) has a Institutional Ownership of 8.12% as of Jul. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Purple Biotech and its competitors.
Is Purple Biotech's Institutional Ownership too high?
Purple Biotech's current Institutional Ownership is 8.12%. Overall, Purple Biotech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Purple Biotech's Institutional Ownership compare to VRTX and REGN?
Purple Biotech's Institutional Ownership of 8.12% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Purple Biotech and its competitors. Purple Biotech's current Institutional Ownership is 8.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Purple Biotech stock overvalued right now?
Purple Biotech (PPBT) has a current Institutional Ownership of 8.12%. The current Institutional Ownership is 8.12%. Purple Biotech's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Purple Biotech (PPBT), the current Institutional Ownership is 8.12% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Purple Biotech Business Description

Other Exchanges PPBT:Israel
Address 4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
19GF Score

Get the complete analysis for PPBT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.35
Price